Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
- PMID: 14519670
- DOI: 10.1096/fj.03-0098fje
Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
Abstract
Parkinson's disease (PD) and other related disorders are characterized by the accumulation of fibrillar aggregates of alpha-synuclein protein (alpha-syn) inside brain cells. It is likely that the formation of alpha-syn aggregates plays a seminal role in the pathogenesis of at least some of these diseases, because two different mutations in the gene encoding alpha-syn have been found in inherited forms of PD. alpha-Syn is mainly expressed by neuronal cells and is generally considered to exist as a cytoplasmic protein. Here, we report the unexpected identification of alpha-syn in conditioned culture media from untransfected and alpha-syn-transfected human neuroblastoma cells, as well as in human cerebrospinal fluid and blood plasma. The method used was immunocapture by using anti-alpha-syn antibodies coupled to magnetic beads, followed by detection on Western blots. In all cases, alpha-syn was identified as a single 15 kDa band, which co-migrated with a recombinant form of the protein and reacted with five different antibodies to alpha-syn. Our findings suggest that cells normally secrete alpha-syn into their surrounding media, both in vitro and in vivo. The detection of extracellular alpha-syn and/or its modified forms in body fluids, particularly in human plasma, offers new opportunities for the development of diagnostic tests for PD and related diseases.
Similar articles
-
Alpha-synuclein and Parkinson's disease.FASEB J. 2004 Apr;18(6):617-26. doi: 10.1096/fj.03-0338rev. FASEB J. 2004. PMID: 15054084 Review.
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.FASEB J. 2006 Mar;20(3):419-25. doi: 10.1096/fj.03-1449com. FASEB J. 2006. PMID: 16507759
-
A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.FASEB J. 2004 Aug;18(11):1315-7. doi: 10.1096/fj.03-1346fje. Epub 2004 Jun 4. FASEB J. 2004. PMID: 15180968
-
Alpha-synuclein: normal function and role in neurodegenerative diseases.Curr Top Dev Biol. 2004;60:17-54. doi: 10.1016/S0070-2153(04)60002-0. Curr Top Dev Biol. 2004. PMID: 15094295 Review.
Cited by
-
Golgi defect as a major contributor to lysosomal dysfunction.Front Cell Dev Biol. 2024 Apr 24;12:1386149. doi: 10.3389/fcell.2024.1386149. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38721528 Free PMC article. Review.
-
Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease.Mol Biol Rep. 2024 Apr 29;51(1):586. doi: 10.1007/s11033-024-09520-7. Mol Biol Rep. 2024. PMID: 38683365 Review.
-
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358. Int J Mol Sci. 2024. PMID: 38673943 Free PMC article. Review.
-
Inhibition of toxic metal-alpha synuclein interactions by human serum albumin.Chem Sci. 2024 Jan 31;15(10):3502-3515. doi: 10.1039/d3sc06285f. eCollection 2024 Mar 6. Chem Sci. 2024. PMID: 38455030 Free PMC article.
-
Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits.Mol Neurobiol. 2024 Feb 27. doi: 10.1007/s12035-024-04035-5. Online ahead of print. Mol Neurobiol. 2024. PMID: 38411868
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous